Drug Ad Crackdown Demonstrates Admin's Aggressive Stance
On Sept. 9, the U.S. Food and Drug Administration issued a press release announcing "sweeping reforms to rein in misleading direct-to-consumer pharmaceutical advertisements,"[1] while simultaneously sending a templated letter[2] to thousands...To view the full article, register now.
Already a subscriber? Click here to view full article